GB1275, a First-in-class CD11b Modulator: Rationale for Immunotherapeutic Combinations in Solid Tumors.
Journal for immunotherapy of cancer（2021）
Key words
myeloid-derived suppressor cells,translational medical research,tumor microenvironment,drug evaluation,preclinical,therapies,investigational
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined